10:57 AM EDT, 04/04/2025 (MT Newswires) -- Charles Cherington, 10% Owner, on April 02, 2025, executed a purchase for 3,768,397 shares in Eterna Therapeutics (ERNA) for $394,174. Following the Form 4 filing with the SEC, Cherington has control over a total of 20,401,602 common shares of the company, with 20,401,602 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/748592/000110465925032060/xslF345X05/tm2511399-2_4seq1.xml

Price: 0.16, Change: -0.02, Percent Change: -12.15